Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
PURPOSE: Recent studies have revealed that branched-chain amino acids (BCAA) reduce the development of hepatocellular carcinoma (HCC) in patients with obesity and hepatitis C virus infection by improving insulin resistance (IR). The aim of this study was to examine the anti-cancer and anti-fibrotic...
Main Authors: | Jung Hoon Cha, Si Hyun Bae, Hye Lim Kim, Na Ri Park, Eun Suk Choi, Eun Sun Jung, Jong Young Choi, Seung Kew Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3815299?pdf=render |
Similar Items
-
Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
by: Jun Sik Yoon, et al.
Published: (2020-07-01) -
Progress in application of branched-chain amino acids in patients with liver cirrhosis
by: LYU Zheng
Published: (2015-03-01) -
Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?
by: Maximiliano Vergara, et al.
Published: (2016-12-01) -
Dietary management and supplementation with branched-chain amino acids in cirrhosis of the liver
by: A. Ruiz-Margáin, et al.
Published: (2018-10-01) -
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
by: Da Jung Kim, et al.
Published: (2019-10-01)